WBH Advisory’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $687K | Sell |
8,044
-220
| -3% | -$19.6K | 0.05% | 200 |
|
|
2025
Q4 | $653K | Sell |
8,264
-51
| -0.6% | -$4K | 0.05% | 206 |
|
|
2025
Q3 | $665K | Sell |
8,315
-210
| -2% | -$17.9K | 0.05% | 206 |
|
|
2025
Q2 | $775K | Sell |
8,525
-56
| -0.7% | -$5.11K | 0.07% | 185 |
|
|
2025
Q1 | $804K | Sell |
8,581
-280
| -3% | -$25.1K | 0.08% | 170 |
|
|
2024
Q4 | $806K | Sell |
8,861
-541
| -6% | -$51.6K | 0.07% | 171 |
|
|
2024
Q3 | $976K | Sell |
9,402
-697
| -7% | -$71K | 0.09% | 154 |
|
|
2024
Q2 | $980K | Sell |
10,099
-253
| -2% | -$23.3K | 0.1% | 146 |
|
|
2024
Q1 | $932K | Sell |
10,352
-413
| -4% | -$35K | 0.1% | 155 |
|
|
2023
Q4 | $858K | Sell |
10,765
-232
| -2% | -$17.4K | 0.1% | 159 |
|
|
2023
Q3 | $782K | Sell |
10,997
-390
| -3% | -$29.2K | 0.1% | 156 |
|
|
2023
Q2 | $877K | Sell |
11,387
-342
| -3% | -$26.5K | 0.1% | 150 |
|
|
2023
Q1 | $881K | Buy |
+11,729
| New | +$872K | 0.11% | 154 |
|
|
2022
Q3 | $830K | Sell |
11,816
-82
| -0.7% | -$6.43K | 0.12% | 153 |
|
|
2022
Q2 | $936K | Sell |
11,898
-316
| -3% | -$24.7K | 0.12% | 144 |
|
|
2022
Q1 | $992K | Sell |
12,214
-653
| -5% | -$51.7K | 0.12% | 145 |
|
|
2021
Q4 | $1.1M | Sell |
12,867
-861
| -6% | -$67.2K | 0.13% | 147 |
|
|
2021
Q3 | $1.04M | Sell |
13,728
-149
| -1% | -$11.8K | 0.14% | 137 |
|
|
2021
Q2 | $1.17M | Sell |
13,877
-1,146
| -8% | -$93.7K | 0.17% | 110 |
|
|
2021
Q1 | $1.18M | Sell |
15,023
-583
| -4% | -$45.7K | 0.19% | 106 |
|
|
2020
Q4 | $1.25M | Buy |
15,606
+4
| +0% | +$331 | 0.22% | 97 |
|
|
2020
Q3 | $1.2M | Sell |
15,602
-353
| -2% | -$26.9K | 0.24% | 89 |
|
|
2020
Q2 | $1.17M | Sell |
15,955
-225
| -1% | -$16K | 0.28% | 88 |
|
|
2020
Q1 | $1.07K | Sell |
16,180
-294
| -2% | -$20.7K | 0.25% | 80 |
|
|
2019
Q4 | $1.13M | Sell |
16,474
-519
| -3% | -$35.4K | 0.23% | 92 |
|
|
2019
Q3 | $1.25M | Sell |
16,993
-849
| -5% | -$61.6K | 0.28% | 86 |
|
|
2019
Q2 | $1.28M | Sell |
17,842
-3,099
| -15% | -$220K | 0.3% | 82 |
|
|
2019
Q1 | $1.44M | Sell |
20,941
-774
| -4% | -$50K | 0.34% | 73 |
|
|
2018
Q4 | $1.29K | Sell |
21,715
-1,023
| -4% | -$64K | 0.31% | 74 |
|
|
2018
Q3 | $1.52M | Sell |
22,738
-723
| -3% | -$48.2K | 0.37% | 65 |
|
|
2018
Q2 | $1.52M | Sell |
23,461
-1,310
| -5% | -$85.7K | 0.39% | 62 |
|
|
2018
Q1 | $1.77M | Sell |
24,771
-579
| -2% | -$41.7K | 0.48% | 48 |
|
|
2017
Q4 | $1.91M | Sell |
25,350
-557
| -2% | -$40.7K | 0.51% | 44 |
|
|
2017
Q3 | $1.89M | Sell |
25,907
-496
| -2% | -$35.7K | 0.53% | 45 |
|
|
2017
Q2 | $1.96M | Sell |
26,403
-329
| -1% | -$24.4K | 0.55% | 44 |
|
|
2017
Q1 | $1.96M | Buy |
26,732
+35
| +0.1% | +$2.45K | 0.59% | 41 |
|
|
2016
Q4 | $1.75M | Sell |
26,697
-834
| -3% | -$57.2K | 0.58% | 43 |
|
|
2016
Q3 | $2.04M | Sell |
27,531
-254
| -0.9% | -$18.8K | 0.7% | 35 |
|
|
2016
Q2 | $2.03M | Sell |
27,785
-762
| -3% | -$54.3K | 0.79% | 31 |
|
|
2016
Q1 | $2.02M | Sell |
28,547
-1,030
| -3% | -$68.5K | 0.67% | 29 |
|
|
2015
Q4 | $1.97K | Sell |
29,577
-1,165
| -4% | -$77.5K | 0.69% | 33 |
|
|
2015
Q3 | $1.95M | Sell |
30,742
-590
| -2% | -$38.5K | 0.81% | 28 |
|
|
2015
Q2 | $2.05M | Sell |
31,332
-659
| -2% | -$44.7K | 0.81% | 28 |
|
|
2015
Q1 | $2.22K | Buy |
31,991
+222
| +0.7% | +$15.3K | 0.62% | 26 |
|
|
2014
Q4 | $2.2M | Sell |
31,769
-810
| -2% | -$54.7K | 0.83% | 28 |
|
|
2014
Q3 | $2.12M | Sell |
32,579
-188
| -0.6% | -$12.4K | 0.75% | 25 |
|
|
2014
Q2 | $2.23M | Sell |
32,767
-503
| -2% | -$33.7K | 0.84% | 22 |
|
|
2014
Q1 | $2.16M | Buy |
33,270
+388
| +1% | +$24.4K | 0.86% | 22 |
|
|
2013
Q4 | $2.14M | Buy |
32,882
+143
| +0.4% | +$9.15K | 0.86% | 23 |
|
|
2013
Q3 | $1.94M | Sell |
32,739
-515
| -2% | -$30.5K | 0.87% | 22 |
|
|
2013
Q2 | $1.91M | Buy |
+33,254
| New | +$1.97M | 0.88% | 26 |
|
Other funds holding CL
VCM
DAM
VPM
WBH Advisory's CL Position: Q1 2026 in Review
WBH Advisory reduced its Colgate-Palmolive (CL) stake by 2.7% in Q1 2026, selling an estimated $19.6K and leaving 8,044 shares worth $687K. The position accounts for 0.05% of the portfolio, ranked #200.
WBH Advisory first reported a position in CL in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.23M in Q2 2014. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- WBH Advisory held 8,044 shares of Colgate-Palmolive worth $687K as of Q1 2026.
- WBH Advisory sold 220 Colgate-Palmolive shares in Q1 2026, an estimated $19.6K.
- Colgate-Palmolive made up 0.05% of WBH Advisory's portfolio in Q1 2026, its #200 holding.
- WBH Advisory first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 51 quarters since.
- WBH Advisory's Colgate-Palmolive position peaked at $2.23M in Q2 2014.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on WBH Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.